Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18432InvestigationalGene Therapies
AGTC-401 is a recombinant adeno-associated virus vector expressing the cyclic nucleotide gated channel beta subunit (rAAV-CNGB3).
- Also known as
- AAV-CNB3 · AAV-PR1.7-hCNGBco vector · AAV2tYF-PR1.7-hCNGB3co · AAV9-PR1.7-hCNGB3co · ACHM CNGB3
- Code names
- AGTC-401
What you can answer from here — as of April 23, 2025
Which companies are running trials of AGTC-401, in which indications and phases, and which of those programs are still active?